Polish clinical practice guideline on Hyperthermic Intraperitoneal Chemotherapy (HIPEC) with Cytoreductice Surgery (CRS) in peritoneal malignancy treatment

Piotr Rutkowski; Beata Śpiewankiewicz; Krzysztof Herman; Tomasz Jastrzębski; Józef Kładny; Zbigniew Kojs; Maciej Krzakowski; Wojciech Polkowski; Lucjan Wyrwicz; Piotr Wysocki; Marcin Zdzienicki; Wojciech Zegarski

Oncology in Clinical Practice
Vol 10, No 6 (2014) Polish clinical practice guideline on Hyperthermic Intraperitoneal Chemotherapy (HIPEC) with Cytoreductice Surgery (CRS) in peritoneal malignancy treatment

Vol 10, No 6 (2014)

Guidelines / Expert consensus

Published online: 2014-01-07

View PDF (Polish) Download PDF file

Page views 702

Article views/downloads 2170

Get Citation

Connect on Social Media

Polish clinical practice guideline on Hyperthermic Intraperitoneal Chemotherapy (HIPEC) with Cytoreductice Surgery (CRS) in peritoneal malignancy treatment

Piotr Rutkowski, Beata Śpiewankiewicz, Krzysztof Herman, Tomasz Jastrzębski, Józef Kładny, Zbigniew Kojs, Maciej Krzakowski, Wojciech Polkowski, Lucjan Wyrwicz, Piotr Wysocki, Marcin Zdzienicki, Wojciech Zegarski

Onkol. Prak. Klin 2014;10(6):283-289.

Abstract

The management of peritoneal surface malignancy is a significant clinical problem. The hyperthermic intraperitoneal chemotherapy (HIPEC) combined with cytoreductive surgery seems to be the most promising method, leading to better local control or improved overall survival in selected patients with a peritoneal neoplasm. In this paper the authors present a consensus for the optimal indications and technical guidelines for performing HIPEC in Poland.

Keywords: peritoneal surface malignancieshiperthermic intraperitoneal chemotherapycytoreductive surgery

Article available in PDF format

View PDF (Polish) Download PDF file

Oncology in Clinical Practice

About Via Medica Advertising

Bookstore (Ikamed) TVMed

News